GO:0032991 | protein-containing complex | 38.73% (79/204) | 1.65 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 30.39% (62/204) | 1.88 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 33.33% (68/204) | 1.72 | 0.0 | 0.0 |
GO:0140513 | nuclear protein-containing complex | 20.1% (41/204) | 2.4 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 37.75% (77/204) | 1.47 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 39.22% (80/204) | 1.31 | 0.0 | 0.0 |
GO:0010468 | regulation of gene expression | 34.31% (70/204) | 1.42 | 0.0 | 0.0 |
GO:0005515 | protein binding | 64.71% (132/204) | 0.77 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 42.65% (87/204) | 1.15 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 22.06% (45/204) | 1.89 | 0.0 | 0.0 |
GO:0005488 | binding | 75.49% (154/204) | 0.59 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 33.33% (68/204) | 1.34 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 45.59% (93/204) | 1.03 | 0.0 | 0.0 |
GO:0016604 | nuclear body | 11.76% (24/204) | 2.76 | 0.0 | 0.0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 34.8% (71/204) | 1.26 | 0.0 | 0.0 |
GO:1902494 | catalytic complex | 18.63% (38/204) | 1.94 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 51.47% (105/204) | 0.88 | 0.0 | 0.0 |
GO:0048522 | positive regulation of cellular process | 33.33% (68/204) | 1.27 | 0.0 | 0.0 |
GO:0031323 | regulation of cellular metabolic process | 36.76% (75/204) | 1.17 | 0.0 | 0.0 |
GO:0016071 | mRNA metabolic process | 13.24% (27/204) | 2.4 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 34.8% (71/204) | 1.21 | 0.0 | 0.0 |
GO:0080090 | regulation of primary metabolic process | 35.29% (72/204) | 1.18 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 16.67% (34/204) | 1.95 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 55.88% (114/204) | 0.74 | 0.0 | 0.0 |
GO:0048518 | positive regulation of biological process | 36.27% (74/204) | 1.07 | 0.0 | 0.0 |
GO:0005654 | nucleoplasm | 16.67% (34/204) | 1.87 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 20.1% (41/204) | 1.63 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 34.8% (71/204) | 1.08 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 23.53% (48/204) | 1.42 | 0.0 | 0.0 |
GO:1990904 | ribonucleoprotein complex | 12.75% (26/204) | 2.16 | 0.0 | 0.0 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 26.47% (54/204) | 1.3 | 0.0 | 0.0 |
GO:0008150 | biological_process | 81.37% (166/204) | 0.4 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 31.37% (64/204) | 1.11 | 0.0 | 0.0 |
GO:0140535 | intracellular protein-containing complex | 11.76% (24/204) | 2.18 | 0.0 | 0.0 |
GO:0009987 | cellular process | 73.04% (149/204) | 0.48 | 0.0 | 0.0 |
GO:0008380 | RNA splicing | 7.35% (15/204) | 2.97 | 0.0 | 0.0 |
GO:0051252 | regulation of RNA metabolic process | 24.51% (50/204) | 1.31 | 0.0 | 0.0 |
GO:0010604 | positive regulation of macromolecule metabolic process | 22.06% (45/204) | 1.4 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 49.02% (100/204) | 0.75 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 43.63% (89/204) | 0.82 | 0.0 | 0.0 |
GO:0065007 | biological regulation | 56.86% (116/204) | 0.63 | 0.0 | 0.0 |
GO:0006397 | mRNA processing | 8.33% (17/204) | 2.61 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 43.63% (89/204) | 0.81 | 0.0 | 0.0 |
GO:0031326 | regulation of cellular biosynthetic process | 27.45% (56/204) | 1.15 | 0.0 | 0.0 |
GO:0010556 | regulation of macromolecule biosynthetic process | 25.0% (51/204) | 1.23 | 0.0 | 0.0 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 20.59% (42/204) | 1.4 | 0.0 | 0.0 |
GO:0016607 | nuclear speck | 6.86% (14/204) | 2.95 | 0.0 | 0.0 |
GO:0009889 | regulation of biosynthetic process | 27.94% (57/204) | 1.13 | 0.0 | 0.0 |
GO:0000398 | mRNA splicing, via spliceosome | 5.39% (11/204) | 3.45 | 0.0 | 1e-06 |
GO:0005684 | U2-type spliceosomal complex | 4.9% (10/204) | 3.63 | 0.0 | 1e-06 |
GO:0044238 | primary metabolic process | 50.98% (104/204) | 0.68 | 0.0 | 1e-06 |
GO:0005681 | spliceosomal complex | 6.37% (13/204) | 2.99 | 0.0 | 1e-06 |
GO:0009893 | positive regulation of metabolic process | 23.04% (47/204) | 1.26 | 0.0 | 1e-06 |
GO:0006357 | regulation of transcription by RNA polymerase II | 12.75% (26/204) | 1.82 | 0.0 | 2e-06 |
GO:0071007 | U2-type catalytic step 2 spliceosome | 3.43% (7/204) | 4.48 | 0.0 | 2e-06 |
GO:0005575 | cellular_component | 78.92% (161/204) | 0.37 | 0.0 | 2e-06 |
GO:0009892 | negative regulation of metabolic process | 20.1% (41/204) | 1.32 | 0.0 | 3e-06 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 5.39% (11/204) | 3.14 | 0.0 | 4e-06 |
GO:0071013 | catalytic step 2 spliceosome | 4.41% (9/204) | 3.58 | 0.0 | 5e-06 |
GO:0010605 | negative regulation of macromolecule metabolic process | 18.63% (38/204) | 1.36 | 0.0 | 5e-06 |
GO:0000375 | RNA splicing, via transesterification reactions | 5.39% (11/204) | 3.1 | 0.0 | 5e-06 |
GO:0043484 | regulation of RNA splicing | 5.39% (11/204) | 3.1 | 0.0 | 5e-06 |
GO:0031325 | positive regulation of cellular metabolic process | 20.1% (41/204) | 1.28 | 0.0 | 5e-06 |
GO:0007626 | locomotory behavior | 3.92% (8/204) | 3.84 | 0.0 | 6e-06 |
GO:0003674 | molecular_function | 76.96% (157/204) | 0.37 | 0.0 | 8e-06 |
GO:0048519 | negative regulation of biological process | 29.41% (60/204) | 0.94 | 0.0 | 1.4e-05 |
GO:0007281 | germ cell development | 4.9% (10/204) | 3.12 | 0.0 | 1.5e-05 |
GO:0006355 | regulation of DNA-templated transcription | 20.59% (42/204) | 1.19 | 0.0 | 1.7e-05 |
GO:2001141 | regulation of RNA biosynthetic process | 20.59% (42/204) | 1.19 | 0.0 | 1.7e-05 |
GO:0051246 | regulation of protein metabolic process | 15.2% (31/204) | 1.45 | 0.0 | 1.7e-05 |
GO:0071840 | cellular component organization or biogenesis | 31.86% (65/204) | 0.87 | 0.0 | 1.7e-05 |
GO:0034655 | nucleobase-containing compound catabolic process | 6.37% (13/204) | 2.59 | 0.0 | 1.7e-05 |
GO:0006259 | DNA metabolic process | 10.29% (21/204) | 1.88 | 0.0 | 1.7e-05 |
GO:0042802 | identical protein binding | 18.63% (38/204) | 1.27 | 0.0 | 1.7e-05 |
GO:1903506 | regulation of nucleic acid-templated transcription | 20.59% (42/204) | 1.19 | 0.0 | 1.7e-05 |
GO:0044237 | cellular metabolic process | 50.98% (104/204) | 0.59 | 0.0 | 1.7e-05 |
GO:0044093 | positive regulation of molecular function | 8.82% (18/204) | 2.07 | 0.0 | 1.8e-05 |
GO:0110165 | cellular anatomical entity | 76.47% (156/204) | 0.35 | 1e-06 | 2.8e-05 |
GO:0045292 | mRNA cis splicing, via spliceosome | 2.94% (6/204) | 4.31 | 1e-06 | 2.8e-05 |
GO:0008334 | histone mRNA metabolic process | 1.96% (4/204) | 5.77 | 1e-06 | 3.2e-05 |
GO:0016043 | cellular component organization | 29.9% (61/204) | 0.87 | 1e-06 | 4.3e-05 |
GO:1990234 | transferase complex | 9.8% (20/204) | 1.82 | 1e-06 | 5.3e-05 |
GO:0071704 | organic substance metabolic process | 53.43% (109/204) | 0.53 | 1e-06 | 5.6e-05 |
GO:0043228 | non-membrane-bounded organelle | 19.61% (40/204) | 1.15 | 1e-06 | 5.7e-05 |
GO:0043232 | intracellular non-membrane-bounded organelle | 19.61% (40/204) | 1.15 | 1e-06 | 5.7e-05 |
GO:0017069 | snRNA binding | 2.94% (6/204) | 4.12 | 1e-06 | 5.7e-05 |
GO:1903832 | regulation of cellular response to amino acid starvation | 1.47% (3/204) | 6.85 | 1e-06 | 5.8e-05 |
GO:1903833 | positive regulation of cellular response to amino acid starvation | 1.47% (3/204) | 6.85 | 1e-06 | 5.8e-05 |
GO:0031056 | regulation of histone modification | 5.39% (11/204) | 2.64 | 2e-06 | 7.6e-05 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3.43% (7/204) | 3.59 | 2e-06 | 8.3e-05 |
GO:0003729 | mRNA binding | 12.25% (25/204) | 1.52 | 2e-06 | 9.6e-05 |
GO:0120114 | Sm-like protein family complex | 3.43% (7/204) | 3.56 | 2e-06 | 9.7e-05 |
GO:0044877 | protein-containing complex binding | 9.31% (19/204) | 1.81 | 3e-06 | 9.9e-05 |
GO:0010629 | negative regulation of gene expression | 8.82% (18/204) | 1.87 | 3e-06 | 0.000102 |
GO:0065009 | regulation of molecular function | 13.73% (28/204) | 1.4 | 3e-06 | 0.000102 |
GO:0044089 | positive regulation of cellular component biogenesis | 4.9% (10/204) | 2.72 | 3e-06 | 0.000132 |
GO:0008589 | regulation of smoothened signaling pathway | 2.94% (6/204) | 3.85 | 4e-06 | 0.000153 |
GO:0060341 | regulation of cellular localization | 7.35% (15/204) | 2.06 | 4e-06 | 0.000153 |
GO:0006302 | double-strand break repair | 4.41% (9/204) | 2.85 | 5e-06 | 0.000189 |
GO:0043414 | macromolecule methylation | 5.39% (11/204) | 2.49 | 5e-06 | 0.000189 |
GO:0005525 | GTP binding | 4.9% (10/204) | 2.63 | 6e-06 | 0.000213 |
GO:0009059 | macromolecule biosynthetic process | 11.27% (23/204) | 1.52 | 6e-06 | 0.000218 |
GO:0044270 | cellular nitrogen compound catabolic process | 6.37% (13/204) | 2.2 | 6e-06 | 0.00022 |
GO:0048513 | animal organ development | 9.31% (19/204) | 1.72 | 6e-06 | 0.000224 |
GO:0046700 | heterocycle catabolic process | 6.37% (13/204) | 2.2 | 6e-06 | 0.000224 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 3.92% (8/204) | 3.04 | 7e-06 | 0.000228 |
GO:0031399 | regulation of protein modification process | 9.31% (19/204) | 1.71 | 7e-06 | 0.000235 |
GO:0071006 | U2-type catalytic step 1 spliceosome | 1.96% (4/204) | 5.0 | 7e-06 | 0.000237 |
GO:0071012 | catalytic step 1 spliceosome | 1.96% (4/204) | 5.0 | 7e-06 | 0.000237 |
GO:0006402 | mRNA catabolic process | 3.92% (8/204) | 3.03 | 7e-06 | 0.000238 |
GO:0008152 | metabolic process | 54.9% (112/204) | 0.47 | 8e-06 | 0.000265 |
GO:0006996 | organelle organization | 17.16% (35/204) | 1.14 | 8e-06 | 0.000272 |
GO:0017070 | U6 snRNA binding | 1.96% (4/204) | 4.94 | 8e-06 | 0.000273 |
GO:0005730 | nucleolus | 10.29% (21/204) | 1.56 | 1e-05 | 0.000327 |
GO:0006281 | DNA repair | 6.86% (14/204) | 2.03 | 1e-05 | 0.00033 |
GO:0032561 | guanyl ribonucleotide binding | 4.9% (10/204) | 2.5 | 1.3e-05 | 0.000404 |
GO:0044087 | regulation of cellular component biogenesis | 7.35% (15/204) | 1.91 | 1.4e-05 | 0.000424 |
GO:0019001 | guanyl nucleotide binding | 4.9% (10/204) | 2.49 | 1.4e-05 | 0.000429 |
GO:0045879 | negative regulation of smoothened signaling pathway | 2.45% (5/204) | 4.02 | 1.5e-05 | 0.000444 |
GO:0048523 | negative regulation of cellular process | 21.57% (44/204) | 0.95 | 1.5e-05 | 0.000447 |
GO:0032880 | regulation of protein localization | 6.37% (13/204) | 2.09 | 1.5e-05 | 0.000448 |
GO:0005829 | cytosol | 25.49% (52/204) | 0.84 | 1.6e-05 | 0.000468 |
GO:0097525 | spliceosomal snRNP complex | 2.94% (6/204) | 3.51 | 1.6e-05 | 0.000469 |
GO:0098772 | molecular function regulator activity | 8.82% (18/204) | 1.68 | 1.6e-05 | 0.000469 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 7.84% (16/204) | 1.81 | 1.6e-05 | 0.000471 |
GO:0008355 | olfactory learning | 1.47% (3/204) | 5.85 | 1.6e-05 | 0.000475 |
GO:0034470 | ncRNA processing | 7.84% (16/204) | 1.8 | 1.7e-05 | 0.000499 |
GO:0048468 | cell development | 7.35% (15/204) | 1.88 | 1.8e-05 | 0.000508 |
GO:0051128 | regulation of cellular component organization | 13.73% (28/204) | 1.24 | 2.1e-05 | 0.0006 |
GO:0008607 | phosphorylase kinase regulator activity | 0.98% (2/204) | 7.58 | 2.7e-05 | 0.000729 |
GO:0048789 | cytoskeletal matrix organization at active zone | 0.98% (2/204) | 7.58 | 2.7e-05 | 0.000729 |
GO:0106261 | tRNA uridine(34) acetyltransferase activity | 0.98% (2/204) | 7.58 | 2.7e-05 | 0.000729 |
GO:2000289 | regulation of photoreceptor cell axon guidance | 0.98% (2/204) | 7.58 | 2.7e-05 | 0.000729 |
GO:1903055 | positive regulation of extracellular matrix organization | 0.98% (2/204) | 7.58 | 2.7e-05 | 0.000729 |
GO:0019079 | viral genome replication | 1.96% (4/204) | 4.54 | 2.6e-05 | 0.000731 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 1.96% (4/204) | 4.54 | 2.6e-05 | 0.000731 |
GO:0032502 | developmental process | 40.2% (82/204) | 0.57 | 2.9e-05 | 0.00078 |
GO:0051304 | chromosome separation | 1.47% (3/204) | 5.58 | 3e-05 | 0.000789 |
GO:0006974 | cellular response to DNA damage stimulus | 7.84% (16/204) | 1.73 | 3.3e-05 | 0.000858 |
GO:0016570 | histone modification | 5.88% (12/204) | 2.08 | 3.3e-05 | 0.00086 |
GO:0009890 | negative regulation of biosynthetic process | 11.27% (23/204) | 1.36 | 3.4e-05 | 0.000879 |
GO:0031324 | negative regulation of cellular metabolic process | 13.73% (28/204) | 1.2 | 3.4e-05 | 0.00088 |
GO:0050684 | regulation of mRNA processing | 3.92% (8/204) | 2.71 | 3.5e-05 | 0.00088 |
GO:0043412 | macromolecule modification | 22.06% (45/204) | 0.88 | 3.4e-05 | 0.000885 |
GO:0006401 | RNA catabolic process | 3.92% (8/204) | 2.7 | 3.7e-05 | 0.000928 |
GO:0042127 | regulation of cell population proliferation | 7.84% (16/204) | 1.71 | 3.7e-05 | 0.000935 |
GO:0007310 | oocyte dorsal/ventral axis specification | 1.47% (3/204) | 5.47 | 3.9e-05 | 0.000953 |
GO:0048749 | compound eye development | 1.47% (3/204) | 5.47 | 3.9e-05 | 0.000953 |
GO:0031647 | regulation of protein stability | 4.9% (10/204) | 2.31 | 4e-05 | 0.000973 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 13.24% (27/204) | 1.21 | 4.3e-05 | 0.001042 |
GO:0007276 | gamete generation | 4.9% (10/204) | 2.3 | 4.3e-05 | 0.001047 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 13.73% (28/204) | 1.18 | 4.5e-05 | 0.001069 |
GO:1904951 | positive regulation of establishment of protein localization | 3.43% (7/204) | 2.91 | 4.5e-05 | 0.001075 |
GO:0043226 | organelle | 53.92% (110/204) | 0.42 | 4.8e-05 | 0.001131 |
GO:0007309 | oocyte axis specification | 1.47% (3/204) | 5.36 | 4.9e-05 | 0.001154 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4.9% (10/204) | 2.26 | 5.2e-05 | 0.001226 |
GO:0050790 | regulation of catalytic activity | 9.31% (19/204) | 1.49 | 5.3e-05 | 0.001243 |
GO:0000785 | chromatin | 5.39% (11/204) | 2.12 | 5.5e-05 | 0.001284 |
GO:0007530 | sex determination | 1.96% (4/204) | 4.26 | 5.7e-05 | 0.001299 |
GO:0032781 | positive regulation of ATP-dependent activity | 1.96% (4/204) | 4.26 | 5.7e-05 | 0.001299 |
GO:0035770 | ribonucleoprotein granule | 4.9% (10/204) | 2.24 | 5.9e-05 | 0.001345 |
GO:0042593 | glucose homeostasis | 2.94% (6/204) | 3.17 | 6e-05 | 0.001355 |
GO:1901888 | regulation of cell junction assembly | 1.96% (4/204) | 4.22 | 6.3e-05 | 0.001408 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 2.45% (5/204) | 3.58 | 6.4e-05 | 0.001439 |
GO:0031401 | positive regulation of protein modification process | 5.88% (12/204) | 1.97 | 6.5e-05 | 0.001451 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 12.75% (26/204) | 1.2 | 6.6e-05 | 0.001455 |
GO:0031327 | negative regulation of cellular biosynthetic process | 10.78% (22/204) | 1.34 | 6.8e-05 | 0.001499 |
GO:0048856 | anatomical structure development | 31.37% (64/204) | 0.65 | 7.3e-05 | 0.00158 |
GO:0051641 | cellular localization | 13.24% (27/204) | 1.16 | 7.6e-05 | 0.001638 |
GO:0043933 | protein-containing complex organization | 10.29% (21/204) | 1.36 | 7.7e-05 | 0.001645 |
GO:0047485 | protein N-terminus binding | 2.45% (5/204) | 3.53 | 7.7e-05 | 0.001646 |
GO:0016462 | pyrophosphatase activity | 5.39% (11/204) | 2.06 | 7.7e-05 | 0.001648 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 0.98% (2/204) | 7.0 | 8.1e-05 | 0.001675 |
GO:0051391 | tRNA acetylation | 0.98% (2/204) | 7.0 | 8.1e-05 | 0.001675 |
GO:1990884 | RNA acetylation | 0.98% (2/204) | 7.0 | 8.1e-05 | 0.001675 |
GO:0034247 | snoRNA splicing | 0.98% (2/204) | 7.0 | 8.1e-05 | 0.001675 |
GO:0043009 | chordate embryonic development | 3.43% (7/204) | 2.77 | 8.2e-05 | 0.001684 |
GO:1904949 | ATPase complex | 2.94% (6/204) | 3.09 | 8.1e-05 | 0.001705 |
GO:0036211 | protein modification process | 19.12% (39/204) | 0.91 | 8.5e-05 | 0.001727 |
GO:0042176 | regulation of protein catabolic process | 4.9% (10/204) | 2.18 | 8.5e-05 | 0.001731 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5.39% (11/204) | 2.04 | 8.6e-05 | 0.001749 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 6.86% (14/204) | 1.75 | 8.9e-05 | 0.00179 |
GO:0019439 | aromatic compound catabolic process | 6.37% (13/204) | 1.83 | 9e-05 | 0.001797 |
GO:1903829 | positive regulation of protein localization | 3.92% (8/204) | 2.51 | 9.2e-05 | 0.001828 |
GO:0070201 | regulation of establishment of protein localization | 4.41% (9/204) | 2.32 | 9.4e-05 | 0.001852 |
GO:0018193 | peptidyl-amino acid modification | 7.84% (16/204) | 1.59 | 9.6e-05 | 0.001889 |
GO:0061136 | regulation of proteasomal protein catabolic process | 3.92% (8/204) | 2.5 | 9.7e-05 | 0.001894 |
GO:0022607 | cellular component assembly | 13.73% (28/204) | 1.11 | 9.9e-05 | 0.001924 |
GO:0009891 | positive regulation of biosynthetic process | 13.73% (28/204) | 1.11 | 0.000106 | 0.002049 |
GO:0099080 | supramolecular complex | 7.84% (16/204) | 1.58 | 0.000109 | 0.00206 |
GO:0016192 | vesicle-mediated transport | 7.84% (16/204) | 1.58 | 0.000109 | 0.00206 |
GO:0090239 | regulation of histone H4 acetylation | 1.47% (3/204) | 5.0 | 0.000108 | 0.002067 |
GO:0016504 | peptidase activator activity | 1.47% (3/204) | 5.0 | 0.000108 | 0.002067 |
GO:0051179 | localization | 23.04% (47/204) | 0.79 | 0.000112 | 0.002119 |
GO:0071826 | ribonucleoprotein complex subunit organization | 4.41% (9/204) | 2.28 | 0.000114 | 0.002133 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 5.39% (11/204) | 1.99 | 0.000119 | 0.002224 |
GO:0010646 | regulation of cell communication | 15.69% (32/204) | 1.0 | 0.000131 | 0.002435 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 1.96% (4/204) | 3.94 | 0.000137 | 0.00254 |
GO:0051130 | positive regulation of cellular component organization | 6.37% (13/204) | 1.76 | 0.000145 | 0.002671 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.43% (7/204) | 2.63 | 0.00015 | 0.002739 |
GO:0018205 | peptidyl-lysine modification | 4.9% (10/204) | 2.07 | 0.000153 | 0.002791 |
GO:0033500 | carbohydrate homeostasis | 2.94% (6/204) | 2.92 | 0.000155 | 0.002801 |
GO:0051247 | positive regulation of protein metabolic process | 7.84% (16/204) | 1.53 | 0.000156 | 0.002806 |
GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage | 0.98% (2/204) | 6.58 | 0.000162 | 0.002855 |
GO:0002926 | tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation | 0.98% (2/204) | 6.58 | 0.000162 | 0.002855 |
GO:1903053 | regulation of extracellular matrix organization | 0.98% (2/204) | 6.58 | 0.000162 | 0.002855 |
GO:0034660 | ncRNA metabolic process | 7.84% (16/204) | 1.53 | 0.000162 | 0.002857 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 2.94% (6/204) | 2.91 | 0.00016 | 0.002874 |
GO:0034708 | methyltransferase complex | 2.94% (6/204) | 2.9 | 0.000166 | 0.002907 |
GO:0035065 | regulation of histone acetylation | 2.45% (5/204) | 3.29 | 0.000169 | 0.002943 |
GO:0007610 | behavior | 4.41% (9/204) | 2.2 | 0.000171 | 0.002969 |
GO:0009950 | dorsal/ventral axis specification | 1.47% (3/204) | 4.77 | 0.000174 | 0.003 |
GO:0035639 | purine ribonucleoside triphosphate binding | 12.75% (26/204) | 1.12 | 0.000176 | 0.003031 |
GO:0032259 | methylation | 5.39% (11/204) | 1.92 | 0.00018 | 0.003083 |
GO:0008047 | enzyme activator activity | 3.92% (8/204) | 2.36 | 0.000185 | 0.003155 |
GO:0043229 | intracellular organelle | 52.45% (107/204) | 0.39 | 0.000194 | 0.003258 |
GO:0031328 | positive regulation of cellular biosynthetic process | 13.24% (27/204) | 1.08 | 0.000193 | 0.003266 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 3.92% (8/204) | 2.35 | 0.000194 | 0.003271 |
GO:0044265 | cellular macromolecule catabolic process | 7.84% (16/204) | 1.5 | 0.000202 | 0.003334 |
GO:0032988 | ribonucleoprotein complex disassembly | 1.47% (3/204) | 4.71 | 0.0002 | 0.003334 |
GO:0005721 | pericentric heterochromatin | 1.47% (3/204) | 4.71 | 0.0002 | 0.003334 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 2.45% (5/204) | 3.23 | 0.000204 | 0.003342 |
GO:0051248 | negative regulation of protein metabolic process | 6.86% (14/204) | 1.63 | 0.000202 | 0.003343 |
GO:1901361 | organic cyclic compound catabolic process | 6.37% (13/204) | 1.71 | 0.000209 | 0.00341 |
GO:0051223 | regulation of protein transport | 3.92% (8/204) | 2.33 | 0.000217 | 0.003527 |
GO:0008340 | determination of adult lifespan | 2.94% (6/204) | 2.83 | 0.000218 | 0.003537 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 9.8% (20/204) | 1.29 | 0.000221 | 0.00356 |
GO:0033036 | macromolecule localization | 11.76% (24/204) | 1.15 | 0.000223 | 0.003576 |
GO:0031400 | negative regulation of protein modification process | 4.41% (9/204) | 2.15 | 0.000225 | 0.003588 |
GO:0031060 | regulation of histone methylation | 3.43% (7/204) | 2.54 | 0.000226 | 0.003591 |
GO:1903050 | regulation of proteolysis involved in protein catabolic process | 3.92% (8/204) | 2.3 | 0.000247 | 0.003917 |
GO:0051222 | positive regulation of protein transport | 2.94% (6/204) | 2.79 | 0.000249 | 0.003929 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 4.41% (9/204) | 2.12 | 0.000256 | 0.00402 |
GO:0030234 | enzyme regulator activity | 6.86% (14/204) | 1.59 | 0.000263 | 0.004082 |
GO:0019538 | protein metabolic process | 22.55% (46/204) | 0.75 | 0.000262 | 0.004085 |
GO:0030981 | cortical microtubule cytoskeleton | 0.98% (2/204) | 6.26 | 0.000268 | 0.00409 |
GO:0051893 | regulation of focal adhesion assembly | 0.98% (2/204) | 6.26 | 0.000268 | 0.00409 |
GO:0090109 | regulation of cell-substrate junction assembly | 0.98% (2/204) | 6.26 | 0.000268 | 0.00409 |
GO:1904813 | ficolin-1-rich granule lumen | 1.96% (4/204) | 3.7 | 0.000262 | 0.004095 |
GO:0009057 | macromolecule catabolic process | 9.31% (19/204) | 1.31 | 0.000268 | 0.00413 |
GO:0031334 | positive regulation of protein-containing complex assembly | 2.45% (5/204) | 3.14 | 0.000277 | 0.004212 |
GO:0032984 | protein-containing complex disassembly | 2.94% (6/204) | 2.76 | 0.000283 | 0.004263 |
GO:0033157 | regulation of intracellular protein transport | 2.94% (6/204) | 2.76 | 0.000283 | 0.004263 |
GO:0009894 | regulation of catabolic process | 7.35% (15/204) | 1.5 | 0.000316 | 0.004738 |
GO:0030155 | regulation of cell adhesion | 2.94% (6/204) | 2.72 | 0.000321 | 0.004789 |
GO:1903311 | regulation of mRNA metabolic process | 4.41% (9/204) | 2.08 | 0.000324 | 0.00482 |
GO:1901983 | regulation of protein acetylation | 2.45% (5/204) | 3.08 | 0.000328 | 0.004855 |
GO:0022411 | cellular component disassembly | 3.92% (8/204) | 2.24 | 0.000332 | 0.004898 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 5.39% (11/204) | 1.81 | 0.000359 | 0.005278 |
GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 3.43% (7/204) | 2.42 | 0.000364 | 0.005326 |
GO:0005667 | transcription regulator complex | 3.92% (8/204) | 2.22 | 0.000367 | 0.005334 |
GO:0019899 | enzyme binding | 11.76% (24/204) | 1.1 | 0.000366 | 0.005337 |
GO:0042048 | olfactory behavior | 1.47% (3/204) | 4.41 | 0.000374 | 0.005402 |
GO:0019903 | protein phosphatase binding | 2.45% (5/204) | 3.03 | 0.000385 | 0.005542 |
GO:0045732 | positive regulation of protein catabolic process | 3.43% (7/204) | 2.41 | 0.000391 | 0.005608 |
GO:0008289 | lipid binding | 5.39% (11/204) | 1.79 | 0.000401 | 0.005622 |
GO:0035800 | deubiquitinase activator activity | 0.98% (2/204) | 6.0 | 0.000401 | 0.005643 |
GO:1903007 | positive regulation of Lys63-specific deubiquitinase activity | 0.98% (2/204) | 6.0 | 0.000401 | 0.005643 |
GO:2000158 | positive regulation of ubiquitin-specific protease activity | 0.98% (2/204) | 6.0 | 0.000401 | 0.005643 |
GO:0004534 | 5'-3' exoribonuclease activity | 0.98% (2/204) | 6.0 | 0.000401 | 0.005643 |
GO:0005078 | MAP-kinase scaffold activity | 0.98% (2/204) | 6.0 | 0.000401 | 0.005643 |
GO:0032106 | positive regulation of response to extracellular stimulus | 1.47% (3/204) | 4.36 | 0.000417 | 0.005798 |
GO:0032109 | positive regulation of response to nutrient levels | 1.47% (3/204) | 4.36 | 0.000417 | 0.005798 |
GO:0010608 | post-transcriptional regulation of gene expression | 6.37% (13/204) | 1.59 | 0.000443 | 0.006142 |
GO:0006338 | chromatin remodeling | 3.92% (8/204) | 2.16 | 0.000483 | 0.006673 |
GO:0031058 | positive regulation of histone modification | 2.94% (6/204) | 2.6 | 0.000497 | 0.006814 |
GO:0045202 | synapse | 4.9% (10/204) | 1.86 | 0.000497 | 0.006831 |
GO:0042981 | regulation of apoptotic process | 5.88% (12/204) | 1.65 | 0.00052 | 0.00705 |
GO:0051254 | positive regulation of RNA metabolic process | 11.27% (23/204) | 1.1 | 0.000519 | 0.00706 |
GO:0007010 | cytoskeleton organization | 6.37% (13/204) | 1.57 | 0.000518 | 0.007075 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 1.96% (4/204) | 3.41 | 0.000562 | 0.007312 |
GO:0032555 | purine ribonucleotide binding | 12.75% (26/204) | 1.01 | 0.000561 | 0.007328 |
GO:0007635 | chemosensory behavior | 1.47% (3/204) | 4.21 | 0.000565 | 0.007335 |
GO:0050807 | regulation of synapse organization | 2.45% (5/204) | 2.92 | 0.00056 | 0.00734 |
GO:0023051 | regulation of signaling | 14.71% (30/204) | 0.92 | 0.000568 | 0.007344 |
GO:0036396 | RNA N6-methyladenosine methyltransferase complex | 0.98% (2/204) | 5.77 | 0.000559 | 0.007364 |
GO:0061053 | somite development | 0.98% (2/204) | 5.77 | 0.000559 | 0.007364 |
GO:0061857 | endoplasmic reticulum stress-induced pre-emptive quality control | 0.98% (2/204) | 5.77 | 0.000559 | 0.007364 |
GO:0106300 | protein-DNA covalent cross-linking repair | 0.98% (2/204) | 5.77 | 0.000559 | 0.007364 |
GO:1903004 | regulation of protein K63-linked deubiquitination | 0.98% (2/204) | 5.77 | 0.000559 | 0.007364 |
GO:1903006 | positive regulation of protein K63-linked deubiquitination | 0.98% (2/204) | 5.77 | 0.000559 | 0.007364 |
GO:1903862 | positive regulation of oxidative phosphorylation | 0.98% (2/204) | 5.77 | 0.000559 | 0.007364 |
GO:0102705 | serine decarboxylase activity | 0.98% (2/204) | 5.77 | 0.000559 | 0.007364 |
GO:0031057 | negative regulation of histone modification | 2.45% (5/204) | 2.89 | 0.000601 | 0.007714 |
GO:0006325 | chromatin organization | 4.41% (9/204) | 1.95 | 0.000604 | 0.007725 |
GO:0032386 | regulation of intracellular transport | 3.43% (7/204) | 2.3 | 0.000601 | 0.007741 |
GO:0003924 | GTPase activity | 3.43% (7/204) | 2.3 | 0.000614 | 0.007827 |
GO:0017076 | purine nucleotide binding | 12.75% (26/204) | 1.0 | 0.000617 | 0.007835 |
GO:1902905 | positive regulation of supramolecular fiber organization | 1.96% (4/204) | 3.37 | 0.000623 | 0.007887 |
GO:0006346 | DNA methylation-dependent heterochromatin formation | 1.96% (4/204) | 3.35 | 0.000655 | 0.008157 |
GO:0031983 | vesicle lumen | 1.96% (4/204) | 3.35 | 0.000655 | 0.008157 |
GO:0034774 | secretory granule lumen | 1.96% (4/204) | 3.35 | 0.000655 | 0.008157 |
GO:0060205 | cytoplasmic vesicle lumen | 1.96% (4/204) | 3.35 | 0.000655 | 0.008157 |
GO:0030111 | regulation of Wnt signaling pathway | 2.94% (6/204) | 2.53 | 0.000652 | 0.008222 |
GO:0046822 | regulation of nucleocytoplasmic transport | 2.45% (5/204) | 2.86 | 0.000667 | 0.008271 |
GO:0051649 | establishment of localization in cell | 9.31% (19/204) | 1.2 | 0.000686 | 0.008479 |
GO:0033588 | elongator holoenzyme complex | 0.98% (2/204) | 5.58 | 0.000743 | 0.008918 |
GO:0042728 | flavin-containing compound catabolic process | 0.98% (2/204) | 5.58 | 0.000743 | 0.008918 |
GO:0072389 | flavin adenine dinucleotide catabolic process | 0.98% (2/204) | 5.58 | 0.000743 | 0.008918 |
GO:1903003 | positive regulation of protein deubiquitination | 0.98% (2/204) | 5.58 | 0.000743 | 0.008918 |
GO:1990730 | VCP-NSFL1C complex | 0.98% (2/204) | 5.58 | 0.000743 | 0.008918 |
GO:2000152 | regulation of ubiquitin-specific protease activity | 0.98% (2/204) | 5.58 | 0.000743 | 0.008918 |
GO:0150116 | regulation of cell-substrate junction organization | 0.98% (2/204) | 5.58 | 0.000743 | 0.008918 |
GO:0051336 | regulation of hydrolase activity | 4.41% (9/204) | 1.91 | 0.000729 | 0.008976 |
GO:0002164 | larval development | 1.96% (4/204) | 3.3 | 0.00076 | 0.009086 |
GO:0042752 | regulation of circadian rhythm | 2.94% (6/204) | 2.49 | 0.000742 | 0.009106 |
GO:0070727 | cellular macromolecule localization | 10.29% (21/204) | 1.12 | 0.000764 | 0.009107 |
GO:0032774 | RNA biosynthetic process | 3.92% (8/204) | 2.05 | 0.00079 | 0.009387 |
GO:0030117 | membrane coat | 1.96% (4/204) | 3.28 | 0.000797 | 0.009439 |
GO:0009966 | regulation of signal transduction | 13.73% (28/204) | 0.92 | 0.00082 | 0.009675 |
GO:0043462 | regulation of ATP-dependent activity | 1.96% (4/204) | 3.26 | 0.000836 | 0.009801 |
GO:0031100 | animal organ regeneration | 1.96% (4/204) | 3.26 | 0.000836 | 0.009801 |
GO:0032553 | ribonucleotide binding | 12.75% (26/204) | 0.97 | 0.000839 | 0.009803 |
GO:0051962 | positive regulation of nervous system development | 2.45% (5/204) | 2.78 | 0.000842 | 0.009809 |
GO:0003712 | transcription coregulator activity | 4.41% (9/204) | 1.88 | 0.000861 | 0.009998 |
GO:0097367 | carbohydrate derivative binding | 13.24% (27/204) | 0.94 | 0.000872 | 0.010094 |
GO:0006305 | DNA alkylation | 1.96% (4/204) | 3.21 | 0.000959 | 0.01054 |
GO:0006306 | DNA methylation | 1.96% (4/204) | 3.21 | 0.000959 | 0.01054 |
GO:0031507 | heterochromatin formation | 2.45% (5/204) | 2.74 | 0.000956 | 0.010567 |
GO:0001510 | RNA methylation | 1.96% (4/204) | 3.22 | 0.000917 | 0.010581 |
GO:0010225 | response to UV-C | 1.47% (3/204) | 3.96 | 0.000955 | 0.010588 |
GO:0000419 | RNA polymerase V complex | 1.47% (3/204) | 3.96 | 0.000955 | 0.010588 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 1.47% (3/204) | 3.96 | 0.000955 | 0.010588 |
GO:0007017 | microtubule-based process | 5.88% (12/204) | 1.55 | 0.000921 | 0.010598 |
GO:0090241 | negative regulation of histone H4 acetylation | 0.98% (2/204) | 5.41 | 0.000953 | 0.010658 |
GO:0005956 | protein kinase CK2 complex | 0.98% (2/204) | 5.41 | 0.000953 | 0.010658 |
GO:0030431 | sleep | 0.98% (2/204) | 5.41 | 0.000953 | 0.010658 |
GO:0016320 | endoplasmic reticulum membrane fusion | 0.98% (2/204) | 5.41 | 0.000953 | 0.010658 |
GO:0007026 | negative regulation of microtubule depolymerization | 0.98% (2/204) | 5.41 | 0.000953 | 0.010658 |
GO:0030971 | receptor tyrosine kinase binding | 0.98% (2/204) | 5.41 | 0.000953 | 0.010658 |
GO:0035591 | signaling adaptor activity | 0.98% (2/204) | 5.41 | 0.000953 | 0.010658 |
GO:0033365 | protein localization to organelle | 5.88% (12/204) | 1.55 | 0.000931 | 0.01068 |
GO:0030162 | regulation of proteolysis | 4.9% (10/204) | 1.74 | 0.000939 | 0.010733 |
GO:0070828 | heterochromatin organization | 2.45% (5/204) | 2.73 | 0.000986 | 0.010803 |
GO:0070647 | protein modification by small protein conjugation or removal | 7.84% (16/204) | 1.28 | 0.001022 | 0.011165 |
GO:0043144 | sno(s)RNA processing | 1.47% (3/204) | 3.92 | 0.001033 | 0.011181 |
GO:0051881 | regulation of mitochondrial membrane potential | 1.47% (3/204) | 3.92 | 0.001033 | 0.011181 |
GO:1903715 | regulation of aerobic respiration | 1.47% (3/204) | 3.92 | 0.001033 | 0.011181 |
GO:0031329 | regulation of cellular catabolic process | 5.88% (12/204) | 1.53 | 0.001037 | 0.011196 |
GO:0043168 | anion binding | 15.2% (31/204) | 0.85 | 0.001046 | 0.011261 |
GO:1905368 | peptidase complex | 1.96% (4/204) | 3.16 | 0.001095 | 0.011751 |
GO:0000974 | Prp19 complex | 1.47% (3/204) | 3.88 | 0.001115 | 0.01189 |
GO:0005669 | transcription factor TFIID complex | 1.47% (3/204) | 3.88 | 0.001115 | 0.01189 |
GO:0009968 | negative regulation of signal transduction | 7.84% (16/204) | 1.27 | 0.001118 | 0.011894 |
GO:0046872 | metal ion binding | 18.14% (37/204) | 0.75 | 0.001151 | 0.012205 |
GO:0051124 | synaptic assembly at neuromuscular junction | 0.98% (2/204) | 5.26 | 0.001187 | 0.012405 |
GO:0035617 | stress granule disassembly | 0.98% (2/204) | 5.26 | 0.001187 | 0.012405 |
GO:0045977 | positive regulation of mitotic cell cycle, embryonic | 0.98% (2/204) | 5.26 | 0.001187 | 0.012405 |
GO:1901857 | positive regulation of cellular respiration | 0.98% (2/204) | 5.26 | 0.001187 | 0.012405 |
GO:1904780 | negative regulation of protein localization to centrosome | 0.98% (2/204) | 5.26 | 0.001187 | 0.012405 |
GO:0009408 | response to heat | 6.86% (14/204) | 1.37 | 0.00119 | 0.012409 |
GO:0007283 | spermatogenesis | 2.94% (6/204) | 2.36 | 0.001201 | 0.012486 |
GO:0019902 | phosphatase binding | 2.45% (5/204) | 2.66 | 0.001254 | 0.013002 |
GO:0033043 | regulation of organelle organization | 6.37% (13/204) | 1.42 | 0.001281 | 0.013239 |
GO:0048813 | dendrite morphogenesis | 1.47% (3/204) | 3.81 | 0.00129 | 0.013298 |
GO:0051495 | positive regulation of cytoskeleton organization | 1.96% (4/204) | 3.09 | 0.001297 | 0.013326 |
GO:0016032 | viral process | 2.94% (6/204) | 2.33 | 0.001315 | 0.013437 |
GO:0010647 | positive regulation of cell communication | 7.35% (15/204) | 1.3 | 0.001311 | 0.013439 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 10.29% (21/204) | 1.05 | 0.001334 | 0.013592 |
GO:0140718 | facultative heterochromatin formation | 1.96% (4/204) | 3.07 | 0.001351 | 0.013728 |
GO:0043085 | positive regulation of catalytic activity | 4.41% (9/204) | 1.78 | 0.00136 | 0.01378 |
GO:0045814 | negative regulation of gene expression, epigenetic | 2.45% (5/204) | 2.61 | 0.001447 | 0.014084 |
GO:0045293 | mRNA editing complex | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:0044233 | mitochondria-associated endoplasmic reticulum membrane | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:1904047 | S-adenosyl-L-methionine binding | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:0030810 | positive regulation of nucleotide biosynthetic process | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:0070841 | inclusion body assembly | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:0070842 | aggresome assembly | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:1900373 | positive regulation of purine nucleotide biosynthetic process | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:2001171 | positive regulation of ATP biosynthetic process | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:0009061 | anaerobic respiration | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:1990782 | protein tyrosine kinase binding | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:0000244 | spliceosomal tri-snRNP complex assembly | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:1900112 | regulation of histone H3-K9 trimethylation | 0.98% (2/204) | 5.12 | 0.001445 | 0.014102 |
GO:0090316 | positive regulation of intracellular protein transport | 1.96% (4/204) | 3.04 | 0.001464 | 0.014206 |
GO:0048477 | oogenesis | 1.96% (4/204) | 3.06 | 0.001406 | 0.014215 |
GO:0019882 | antigen processing and presentation | 1.47% (3/204) | 3.74 | 0.001482 | 0.014272 |
GO:0016074 | sno(s)RNA metabolic process | 1.47% (3/204) | 3.74 | 0.001482 | 0.014272 |
GO:0031519 | PcG protein complex | 1.47% (3/204) | 3.74 | 0.001482 | 0.014272 |
GO:0019887 | protein kinase regulator activity | 2.45% (5/204) | 2.6 | 0.001488 | 0.014293 |
GO:0009792 | embryo development ending in birth or egg hatching | 3.43% (7/204) | 2.09 | 0.001433 | 0.014444 |
GO:0071011 | precatalytic spliceosome | 1.96% (4/204) | 3.03 | 0.001523 | 0.014584 |
GO:0023057 | negative regulation of signaling | 7.84% (16/204) | 1.22 | 0.001558 | 0.014889 |
GO:1903076 | regulation of protein localization to plasma membrane | 1.96% (4/204) | 3.01 | 0.001583 | 0.014929 |
GO:0044728 | DNA methylation or demethylation | 1.96% (4/204) | 3.01 | 0.001583 | 0.014929 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.96% (4/204) | 3.01 | 0.001583 | 0.014929 |
GO:0070918 | small regulatory ncRNA processing | 2.45% (5/204) | 2.58 | 0.001573 | 0.014988 |
GO:0010648 | negative regulation of cell communication | 7.84% (16/204) | 1.22 | 0.001583 | 0.015041 |
GO:0051240 | positive regulation of multicellular organismal process | 6.86% (14/204) | 1.32 | 0.001607 | 0.015116 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 5.88% (12/204) | 1.46 | 0.001615 | 0.015154 |
GO:0000428 | DNA-directed RNA polymerase complex | 1.96% (4/204) | 3.0 | 0.001645 | 0.015396 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.45% (5/204) | 2.56 | 0.001661 | 0.015505 |
GO:0043169 | cation binding | 18.14% (37/204) | 0.71 | 0.00173 | 0.015706 |
GO:0030030 | cell projection organization | 3.92% (8/204) | 1.87 | 0.001734 | 0.015706 |
GO:0050821 | protein stabilization | 2.94% (6/204) | 2.25 | 0.001741 | 0.015728 |
GO:0035561 | regulation of chromatin binding | 0.98% (2/204) | 5.0 | 0.001728 | 0.015731 |
GO:0039694 | viral RNA genome replication | 0.98% (2/204) | 5.0 | 0.001728 | 0.015731 |
GO:0050765 | negative regulation of phagocytosis | 0.98% (2/204) | 5.0 | 0.001728 | 0.015731 |
GO:2000025 | regulation of leaf formation | 0.98% (2/204) | 5.0 | 0.001728 | 0.015731 |
GO:0042288 | MHC class I protein binding | 0.98% (2/204) | 5.0 | 0.001728 | 0.015731 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 0.98% (2/204) | 5.0 | 0.001728 | 0.015731 |
GO:0051010 | microtubule plus-end binding | 0.98% (2/204) | 5.0 | 0.001728 | 0.015731 |
GO:0019207 | kinase regulator activity | 2.45% (5/204) | 2.55 | 0.001753 | 0.015798 |
GO:0070717 | poly-purine tract binding | 1.96% (4/204) | 2.98 | 0.001709 | 0.015831 |
GO:0010494 | cytoplasmic stress granule | 2.45% (5/204) | 2.56 | 0.001707 | 0.015848 |
GO:0000932 | P-body | 2.45% (5/204) | 2.56 | 0.001707 | 0.015848 |
GO:0140030 | modification-dependent protein binding | 2.45% (5/204) | 2.52 | 0.001897 | 0.017058 |
GO:0032446 | protein modification by small protein conjugation | 6.86% (14/204) | 1.3 | 0.001921 | 0.017224 |
GO:0030177 | positive regulation of Wnt signaling pathway | 1.96% (4/204) | 2.92 | 0.001982 | 0.017685 |
GO:0007292 | female gamete generation | 1.96% (4/204) | 2.92 | 0.001982 | 0.017685 |
GO:0071014 | post-mRNA release spliceosomal complex | 1.47% (3/204) | 3.58 | 0.002038 | 0.017755 |
GO:0051726 | regulation of cell cycle | 6.86% (14/204) | 1.29 | 0.002036 | 0.017777 |
GO:0080009 | mRNA methylation | 0.98% (2/204) | 4.88 | 0.002036 | 0.017819 |
GO:0006265 | DNA topological change | 0.98% (2/204) | 4.88 | 0.002036 | 0.017819 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 0.98% (2/204) | 4.88 | 0.002036 | 0.017819 |
GO:0036513 | Derlin-1 retrotranslocation complex | 0.98% (2/204) | 4.88 | 0.002036 | 0.017819 |
GO:0061909 | autophagosome-lysosome fusion | 0.98% (2/204) | 4.88 | 0.002036 | 0.017819 |
GO:0072387 | flavin adenine dinucleotide metabolic process | 0.98% (2/204) | 4.88 | 0.002036 | 0.017819 |
GO:0030132 | clathrin coat of coated pit | 0.98% (2/204) | 4.88 | 0.002036 | 0.017819 |
GO:0032879 | regulation of localization | 9.8% (20/204) | 1.03 | 0.002022 | 0.018004 |
GO:0043067 | regulation of programmed cell death | 6.86% (14/204) | 1.28 | 0.002104 | 0.018287 |
GO:0070925 | organelle assembly | 4.41% (9/204) | 1.69 | 0.002122 | 0.018397 |
GO:0015030 | Cajal body | 1.47% (3/204) | 3.55 | 0.002163 | 0.018707 |
GO:1904375 | regulation of protein localization to cell periphery | 1.96% (4/204) | 2.88 | 0.002205 | 0.019027 |
GO:0072665 | protein localization to vacuole | 2.45% (5/204) | 2.46 | 0.002268 | 0.019483 |
GO:0043254 | regulation of protein-containing complex assembly | 2.94% (6/204) | 2.18 | 0.002264 | 0.019495 |
GO:0008143 | poly(A) binding | 1.47% (3/204) | 3.52 | 0.002292 | 0.019502 |
GO:0000502 | proteasome complex | 1.47% (3/204) | 3.52 | 0.002292 | 0.019502 |
GO:0030880 | RNA polymerase complex | 1.96% (4/204) | 2.87 | 0.002283 | 0.019516 |
GO:0042254 | ribosome biogenesis | 1.96% (4/204) | 2.87 | 0.002283 | 0.019516 |
GO:0040021 | hermaphrodite germ-line sex determination | 0.98% (2/204) | 4.77 | 0.002367 | 0.019637 |
GO:0040022 | feminization of hermaphroditic germ-line | 0.98% (2/204) | 4.77 | 0.002367 | 0.019637 |
GO:0009794 | regulation of mitotic cell cycle, embryonic | 0.98% (2/204) | 4.77 | 0.002367 | 0.019637 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 0.98% (2/204) | 4.77 | 0.002367 | 0.019637 |
GO:0042287 | MHC protein binding | 0.98% (2/204) | 4.77 | 0.002367 | 0.019637 |
GO:0090085 | regulation of protein deubiquitination | 0.98% (2/204) | 4.77 | 0.002367 | 0.019637 |
GO:1904288 | BAT3 complex binding | 0.98% (2/204) | 4.77 | 0.002367 | 0.019637 |
GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA | 0.98% (2/204) | 4.77 | 0.002367 | 0.019637 |
GO:0001952 | regulation of cell-matrix adhesion | 0.98% (2/204) | 4.77 | 0.002367 | 0.019637 |
GO:0006310 | DNA recombination | 2.94% (6/204) | 2.16 | 0.002401 | 0.019872 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 3.92% (8/204) | 1.79 | 0.00241 | 0.019907 |
GO:0140694 | non-membrane-bounded organelle assembly | 3.43% (7/204) | 1.95 | 0.002426 | 0.019951 |
GO:0048232 | male gamete generation | 2.94% (6/204) | 2.17 | 0.002354 | 0.019989 |
GO:0006403 | RNA localization | 1.47% (3/204) | 3.49 | 0.002426 | 0.019991 |
GO:0007041 | lysosomal transport | 1.96% (4/204) | 2.85 | 0.002363 | 0.020013 |
GO:1903008 | organelle disassembly | 1.96% (4/204) | 2.84 | 0.002445 | 0.020057 |
GO:0009896 | positive regulation of catabolic process | 4.41% (9/204) | 1.66 | 0.00246 | 0.02014 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 1.96% (4/204) | 2.83 | 0.002529 | 0.020652 |
GO:0048870 | cell motility | 2.94% (6/204) | 2.13 | 0.002641 | 0.021521 |
GO:0006359 | regulation of transcription by RNA polymerase III | 0.98% (2/204) | 4.68 | 0.002721 | 0.021554 |
GO:0045475 | locomotor rhythm | 0.98% (2/204) | 4.68 | 0.002721 | 0.021554 |
GO:0002168 | instar larval development | 0.98% (2/204) | 4.68 | 0.002721 | 0.021554 |
GO:0000835 | ER ubiquitin ligase complex | 0.98% (2/204) | 4.68 | 0.002721 | 0.021554 |
GO:0000836 | Hrd1p ubiquitin ligase complex | 0.98% (2/204) | 4.68 | 0.002721 | 0.021554 |
GO:1903580 | positive regulation of ATP metabolic process | 0.98% (2/204) | 4.68 | 0.002721 | 0.021554 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 0.98% (2/204) | 4.68 | 0.002721 | 0.021554 |
GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA | 0.98% (2/204) | 4.68 | 0.002721 | 0.021554 |
GO:0051255 | spindle midzone assembly | 0.98% (2/204) | 4.68 | 0.002721 | 0.021554 |
GO:0072594 | establishment of protein localization to organelle | 3.92% (8/204) | 1.77 | 0.002652 | 0.021567 |
GO:0015031 | protein transport | 6.86% (14/204) | 1.24 | 0.002766 | 0.021856 |
GO:0046540 | U4/U6 x U5 tri-snRNP complex | 1.47% (3/204) | 3.44 | 0.002708 | 0.021874 |
GO:0008306 | associative learning | 1.47% (3/204) | 3.44 | 0.002708 | 0.021874 |
GO:0070603 | SWI/SNF superfamily-type complex | 1.96% (4/204) | 2.8 | 0.002702 | 0.021922 |
GO:0006304 | DNA modification | 1.96% (4/204) | 2.79 | 0.002792 | 0.021968 |
GO:0008237 | metallopeptidase activity | 1.96% (4/204) | 2.79 | 0.002792 | 0.021968 |
GO:0007275 | multicellular organism development | 12.25% (25/204) | 0.86 | 0.002862 | 0.022328 |
GO:0030120 | vesicle coat | 1.47% (3/204) | 3.41 | 0.002856 | 0.022333 |
GO:0097526 | spliceosomal tri-snRNP complex | 1.47% (3/204) | 3.41 | 0.002856 | 0.022333 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.47% (3/204) | 3.41 | 0.002856 | 0.022333 |
GO:0052548 | regulation of endopeptidase activity | 2.45% (5/204) | 2.37 | 0.002954 | 0.022996 |
GO:0034063 | stress granule assembly | 1.47% (3/204) | 3.39 | 0.00301 | 0.023283 |
GO:1905369 | endopeptidase complex | 1.47% (3/204) | 3.39 | 0.00301 | 0.023283 |
GO:0008104 | protein localization | 8.82% (18/204) | 1.05 | 0.003001 | 0.023312 |
GO:0045892 | negative regulation of DNA-templated transcription | 7.35% (15/204) | 1.17 | 0.003026 | 0.023357 |
GO:0097746 | blood vessel diameter maintenance | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:0060810 | intracellular mRNA localization involved in pattern specification process | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:0002098 | tRNA wobble uridine modification | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:0035096 | larval midgut cell programmed cell death | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:0045838 | positive regulation of membrane potential | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:0045981 | positive regulation of nucleotide metabolic process | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:1900544 | positive regulation of purine nucleotide metabolic process | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:1903842 | response to arsenite ion | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:1903843 | cellular response to arsenite ion | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:0031116 | positive regulation of microtubule polymerization | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:0071564 | npBAF complex | 0.98% (2/204) | 4.58 | 0.0031 | 0.023384 |
GO:0033554 | cellular response to stress | 15.69% (32/204) | 0.73 | 0.003118 | 0.023425 |
GO:0005543 | phospholipid binding | 3.43% (7/204) | 1.89 | 0.003112 | 0.023432 |
GO:0000792 | heterochromatin | 1.96% (4/204) | 2.74 | 0.003171 | 0.023631 |
GO:0051091 | positive regulation of DNA-binding transcription factor activity | 1.96% (4/204) | 2.74 | 0.003171 | 0.023631 |
GO:0000793 | condensed chromosome | 1.96% (4/204) | 2.74 | 0.003171 | 0.023631 |
GO:0042306 | regulation of protein import into nucleus | 1.47% (3/204) | 3.36 | 0.003168 | 0.023753 |
GO:1902679 | negative regulation of RNA biosynthetic process | 7.35% (15/204) | 1.16 | 0.003253 | 0.024144 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 7.35% (15/204) | 1.16 | 0.003253 | 0.024144 |
GO:0007059 | chromosome segregation | 1.96% (4/204) | 2.72 | 0.003271 | 0.02418 |
GO:0000226 | microtubule cytoskeleton organization | 4.41% (9/204) | 1.59 | 0.003266 | 0.024191 |
GO:0043543 | protein acylation | 2.94% (6/204) | 2.06 | 0.00335 | 0.024714 |
GO:0051345 | positive regulation of hydrolase activity | 2.45% (5/204) | 2.33 | 0.003385 | 0.024873 |
GO:0043167 | ion binding | 25.98% (53/204) | 0.52 | 0.003381 | 0.024893 |
GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 0.98% (2/204) | 4.49 | 0.003501 | 0.025166 |
GO:0007528 | neuromuscular junction development | 0.98% (2/204) | 4.49 | 0.003501 | 0.025166 |
GO:1904779 | regulation of protein localization to centrosome | 0.98% (2/204) | 4.49 | 0.003501 | 0.025166 |
GO:2001169 | regulation of ATP biosynthetic process | 0.98% (2/204) | 4.49 | 0.003501 | 0.025166 |
GO:0046033 | AMP metabolic process | 0.98% (2/204) | 4.49 | 0.003501 | 0.025166 |
GO:0030125 | clathrin vesicle coat | 0.98% (2/204) | 4.49 | 0.003501 | 0.025166 |
GO:0071565 | nBAF complex | 0.98% (2/204) | 4.49 | 0.003501 | 0.025166 |
GO:0051965 | positive regulation of synapse assembly | 0.98% (2/204) | 4.49 | 0.003501 | 0.025166 |
GO:1901890 | positive regulation of cell junction assembly | 0.98% (2/204) | 4.49 | 0.003501 | 0.025166 |
GO:0044297 | cell body | 2.94% (6/204) | 2.05 | 0.003471 | 0.02545 |
GO:0043457 | regulation of cellular respiration | 1.47% (3/204) | 3.31 | 0.0035 | 0.02561 |
GO:0051253 | negative regulation of RNA metabolic process | 7.84% (16/204) | 1.1 | 0.003638 | 0.0261 |
GO:0016073 | snRNA metabolic process | 1.47% (3/204) | 3.28 | 0.003673 | 0.026249 |
GO:0008320 | protein transmembrane transporter activity | 1.47% (3/204) | 3.28 | 0.003673 | 0.026249 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 8.33% (17/204) | 1.05 | 0.003791 | 0.026985 |
GO:0016567 | protein ubiquitination | 6.37% (13/204) | 1.24 | 0.0038 | 0.026996 |
GO:0051239 | regulation of multicellular organismal process | 13.73% (28/204) | 0.77 | 0.003788 | 0.027018 |
GO:0045893 | positive regulation of DNA-templated transcription | 9.31% (19/204) | 0.98 | 0.003822 | 0.027103 |
GO:0035067 | negative regulation of histone acetylation | 1.47% (3/204) | 3.26 | 0.003852 | 0.027207 |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.47% (3/204) | 3.26 | 0.003852 | 0.027207 |
GO:0034045 | phagophore assembly site membrane | 0.98% (2/204) | 4.41 | 0.003925 | 0.027407 |
GO:0048599 | oocyte development | 0.98% (2/204) | 4.41 | 0.003925 | 0.027407 |
GO:1902667 | regulation of axon guidance | 0.98% (2/204) | 4.41 | 0.003925 | 0.027407 |
GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex | 0.98% (2/204) | 4.41 | 0.003925 | 0.027407 |
GO:0036435 | K48-linked polyubiquitin modification-dependent protein binding | 0.98% (2/204) | 4.41 | 0.003925 | 0.027407 |
GO:1901673 | regulation of mitotic spindle assembly | 0.98% (2/204) | 4.41 | 0.003925 | 0.027407 |
GO:0003677 | DNA binding | 14.22% (29/204) | 0.75 | 0.003966 | 0.027641 |
GO:0010638 | positive regulation of organelle organization | 3.43% (7/204) | 1.82 | 0.003994 | 0.027732 |
GO:1903578 | regulation of ATP metabolic process | 1.47% (3/204) | 3.24 | 0.004035 | 0.027755 |
GO:0043242 | negative regulation of protein-containing complex disassembly | 1.47% (3/204) | 3.24 | 0.004035 | 0.027755 |
GO:0010941 | regulation of cell death | 7.35% (15/204) | 1.13 | 0.003993 | 0.027778 |
GO:1901564 | organonitrogen compound metabolic process | 29.9% (61/204) | 0.46 | 0.00406 | 0.027821 |
GO:0008017 | microtubule binding | 2.94% (6/204) | 2.01 | 0.004054 | 0.027829 |
GO:0032104 | regulation of response to extracellular stimulus | 1.96% (4/204) | 2.64 | 0.004032 | 0.027838 |
GO:0032107 | regulation of response to nutrient levels | 1.96% (4/204) | 2.64 | 0.004032 | 0.027838 |
GO:0060429 | epithelium development | 1.96% (4/204) | 2.64 | 0.004032 | 0.027838 |
GO:0040012 | regulation of locomotion | 3.43% (7/204) | 1.81 | 0.004109 | 0.028105 |
GO:0034645 | cellular macromolecule biosynthetic process | 5.88% (12/204) | 1.28 | 0.004227 | 0.028589 |
GO:0000791 | euchromatin | 1.47% (3/204) | 3.21 | 0.004225 | 0.028625 |
GO:0001654 | eye development | 1.47% (3/204) | 3.21 | 0.004225 | 0.028625 |
GO:0007040 | lysosome organization | 1.47% (3/204) | 3.21 | 0.004225 | 0.028625 |
GO:0035861 | site of double-strand break | 1.47% (3/204) | 3.21 | 0.004225 | 0.028625 |
GO:0034605 | cellular response to heat | 2.94% (6/204) | 1.99 | 0.004263 | 0.028729 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 9.31% (19/204) | 0.97 | 0.004215 | 0.028771 |
GO:1902680 | positive regulation of RNA biosynthetic process | 9.31% (19/204) | 0.97 | 0.004263 | 0.028779 |
GO:0006886 | intracellular protein transport | 5.39% (11/204) | 1.35 | 0.004319 | 0.029052 |
GO:1902005 | regulation of proline biosynthetic process | 0.98% (2/204) | 4.33 | 0.004372 | 0.029137 |
GO:1902006 | negative regulation of proline biosynthetic process | 0.98% (2/204) | 4.33 | 0.004372 | 0.029137 |
GO:2000215 | negative regulation of proline metabolic process | 0.98% (2/204) | 4.33 | 0.004372 | 0.029137 |
GO:2000283 | negative regulation of cellular amino acid biosynthetic process | 0.98% (2/204) | 4.33 | 0.004372 | 0.029137 |
GO:0009158 | ribonucleoside monophosphate catabolic process | 0.98% (2/204) | 4.33 | 0.004372 | 0.029137 |
GO:0098978 | glutamatergic synapse | 2.45% (5/204) | 2.24 | 0.004381 | 0.029147 |
GO:0007052 | mitotic spindle organization | 1.96% (4/204) | 2.6 | 0.004392 | 0.029167 |
GO:0008284 | positive regulation of cell population proliferation | 3.92% (8/204) | 1.65 | 0.004423 | 0.029214 |
GO:1901799 | negative regulation of proteasomal protein catabolic process | 1.47% (3/204) | 3.19 | 0.004419 | 0.029238 |
GO:0080171 | lytic vacuole organization | 1.47% (3/204) | 3.19 | 0.004419 | 0.029238 |
GO:1905475 | regulation of protein localization to membrane | 1.96% (4/204) | 2.59 | 0.004517 | 0.029672 |
GO:0032388 | positive regulation of intracellular transport | 1.96% (4/204) | 2.59 | 0.004517 | 0.029672 |
GO:0035097 | histone methyltransferase complex | 1.96% (4/204) | 2.59 | 0.004517 | 0.029672 |
GO:0042803 | protein homodimerization activity | 6.86% (14/204) | 1.15 | 0.004572 | 0.02998 |
GO:0045763 | negative regulation of cellular amino acid metabolic process | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:2000282 | regulation of cellular amino acid biosynthetic process | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:0002097 | tRNA wobble base modification | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:0051228 | mitotic spindle disassembly | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:0051230 | spindle disassembly | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:0097352 | autophagosome maturation | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:0030955 | potassium ion binding | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:0090169 | regulation of spindle assembly | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:0048306 | calcium-dependent protein binding | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:0009125 | nucleoside monophosphate catabolic process | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:0051231 | spindle elongation | 0.98% (2/204) | 4.19 | 0.005332 | 0.030062 |
GO:0033168 | obsolete conversion of ds siRNA to ss siRNA involved in RNA interference | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0140262 | mRNA cap binding complex binding | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0031128 | developmental induction | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0031129 | inductive cell-cell signaling | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0006061 | sorbitol biosynthetic process | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0006700 | C21-steroid hormone biosynthetic process | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0018505 | cis-1,2-dihydro-1,2-dihydroxynaphthalene dehydrogenase activity | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0019406 | hexitol biosynthetic process | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0033010 | paranodal junction | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0042629 | mast cell granule | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0043795 | glyceraldehyde oxidoreductase activity | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0047641 | aldose-6-phosphate reductase (NADPH) activity | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0072061 | inner medullary collecting duct development | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0097238 | cellular response to methylglyoxal | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0097454 | Schwann cell microvillus | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0055015 | ventricular cardiac muscle cell development | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0061739 | protein lipidation involved in autophagosome assembly | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0071500 | cellular response to nitrosative stress | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0033696 | heterochromatin boundary formation | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0048189 | Lid2 complex | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0046594 | maintenance of pole plasm mRNA location | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0051237 | maintenance of RNA location | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:1905881 | positive regulation of oogenesis | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0048593 | camera-type eye morphogenesis | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0032437 | cuticular plate | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0000296 | spermine transport | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0001097 | TFIIH-class transcription factor complex binding | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0045344 | negative regulation of MHC class I biosynthetic process | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0050072 | m7G(5')pppN diphosphatase activity | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0090152 | establishment of protein localization to mitochondrial membrane involved in mitochondrial fission | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0098773 | skin epidermis development | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0070590 | spore wall biogenesis | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0030548 | acetylcholine receptor regulator activity | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0045213 | neurotransmitter receptor metabolic process | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0090044 | positive regulation of tubulin deacetylation | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0090045 | positive regulation of deacetylase activity | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0099602 | neurotransmitter receptor regulator activity | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0071166 | ribonucleoprotein complex localization | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0010992 | ubiquitin recycling | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0031626 | beta-endorphin binding | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0042165 | neurotransmitter binding | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0043559 | insulin binding | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:1901142 | insulin metabolic process | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:1901143 | insulin catabolic process | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0003837 | beta-ureidopropionase activity | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0033396 | beta-alanine biosynthetic process via 3-ureidopropionate | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0046074 | dTMP catabolic process | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0008716 | D-alanine-D-alanine ligase activity | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0035598 | N6-threonylcarbomyladenosine methylthiotransferase activity | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:1990798 | pancreas regeneration | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0000412 | histone peptidyl-prolyl isomerization | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:0048453 | sepal formation | 0.49% (1/204) | 7.58 | 0.005219 | 0.030073 |
GO:1900542 | regulation of purine nucleotide metabolic process | 1.47% (3/204) | 3.1 | 0.00525 | 0.03011 |
GO:0098813 | nuclear chromosome segregation | 1.47% (3/204) | 3.1 | 0.00525 | 0.03011 |
GO:0046907 | intracellular transport | 7.35% (15/204) | 1.08 | 0.005235 | 0.030118 |
GO:0022884 | macromolecule transmembrane transporter activity | 1.47% (3/204) | 3.17 | 0.004619 | 0.030232 |
GO:0031123 | RNA 3'-end processing | 1.96% (4/204) | 2.58 | 0.004644 | 0.030342 |
GO:0016573 | histone acetylation | 2.45% (5/204) | 2.22 | 0.00466 | 0.030391 |
GO:0065003 | protein-containing complex assembly | 7.35% (15/204) | 1.08 | 0.005446 | 0.030656 |
GO:0005844 | polysome | 1.47% (3/204) | 3.08 | 0.005472 | 0.03066 |
GO:0010950 | positive regulation of endopeptidase activity | 1.47% (3/204) | 3.08 | 0.005472 | 0.03066 |
GO:0048812 | neuron projection morphogenesis | 1.96% (4/204) | 2.52 | 0.005456 | 0.030669 |
GO:0035296 | regulation of tube diameter | 0.98% (2/204) | 4.26 | 0.004841 | 0.030966 |
GO:0002165 | instar larval or pupal development | 0.98% (2/204) | 4.26 | 0.004841 | 0.030966 |
GO:0045169 | fusome | 0.98% (2/204) | 4.26 | 0.004841 | 0.030966 |
GO:0006580 | ethanolamine metabolic process | 0.98% (2/204) | 4.26 | 0.004841 | 0.030966 |
GO:0046330 | positive regulation of JNK cascade | 0.98% (2/204) | 4.26 | 0.004841 | 0.030966 |
GO:0061025 | membrane fusion | 1.96% (4/204) | 2.57 | 0.004773 | 0.031022 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 1.96% (4/204) | 2.57 | 0.004773 | 0.031022 |
GO:0070300 | phosphatidic acid binding | 1.47% (3/204) | 3.14 | 0.004824 | 0.031129 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.47% (3/204) | 3.14 | 0.004824 | 0.031129 |
GO:0046328 | regulation of JNK cascade | 1.47% (3/204) | 3.14 | 0.004824 | 0.031129 |
GO:0045184 | establishment of protein localization | 6.86% (14/204) | 1.15 | 0.004806 | 0.03118 |
GO:0008092 | cytoskeletal protein binding | 4.9% (10/204) | 1.41 | 0.004895 | 0.031256 |
GO:2000145 | regulation of cell motility | 2.94% (6/204) | 1.91 | 0.005605 | 0.03136 |
GO:0006475 | internal protein amino acid acetylation | 2.45% (5/204) | 2.2 | 0.00495 | 0.031501 |
GO:0018393 | internal peptidyl-lysine acetylation | 2.45% (5/204) | 2.2 | 0.00495 | 0.031501 |
GO:0006497 | protein lipidation | 1.47% (3/204) | 3.06 | 0.005699 | 0.031834 |
GO:1905477 | positive regulation of protein localization to membrane | 1.47% (3/204) | 3.12 | 0.005034 | 0.031869 |
GO:2000757 | negative regulation of peptidyl-lysine acetylation | 1.47% (3/204) | 3.12 | 0.005034 | 0.031869 |
GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 1.47% (3/204) | 3.12 | 0.005034 | 0.031869 |
GO:0051656 | establishment of organelle localization | 3.43% (7/204) | 1.76 | 0.005054 | 0.031884 |
GO:0018394 | peptidyl-lysine acetylation | 2.45% (5/204) | 2.19 | 0.00505 | 0.031914 |
GO:0031062 | positive regulation of histone methylation | 1.96% (4/204) | 2.49 | 0.005747 | 0.031959 |
GO:0048858 | cell projection morphogenesis | 1.96% (4/204) | 2.49 | 0.005747 | 0.031959 |
GO:0120039 | plasma membrane bounded cell projection morphogenesis | 1.96% (4/204) | 2.49 | 0.005747 | 0.031959 |
GO:0003697 | single-stranded DNA binding | 2.45% (5/204) | 2.14 | 0.005788 | 0.03209 |
GO:0051098 | regulation of binding | 2.94% (6/204) | 1.9 | 0.005781 | 0.0321 |
GO:0030334 | regulation of cell migration | 2.94% (6/204) | 1.94 | 0.005101 | 0.032123 |
GO:0018992 | germ-line sex determination | 0.98% (2/204) | 4.12 | 0.005845 | 0.032162 |
GO:0030808 | regulation of nucleotide biosynthetic process | 0.98% (2/204) | 4.12 | 0.005845 | 0.032162 |
GO:1900371 | regulation of purine nucleotide biosynthetic process | 0.98% (2/204) | 4.12 | 0.005845 | 0.032162 |
GO:0006337 | nucleosome disassembly | 0.98% (2/204) | 4.12 | 0.005845 | 0.032162 |
GO:0070122 | obsolete isopeptidase activity | 0.98% (2/204) | 4.12 | 0.005845 | 0.032162 |
GO:0051960 | regulation of nervous system development | 2.45% (5/204) | 2.14 | 0.0059 | 0.032364 |
GO:0007051 | spindle organization | 2.45% (5/204) | 2.14 | 0.0059 | 0.032364 |
GO:0043244 | regulation of protein-containing complex disassembly | 1.96% (4/204) | 2.47 | 0.006048 | 0.033128 |
GO:0010564 | regulation of cell cycle process | 4.9% (10/204) | 1.36 | 0.006115 | 0.033445 |
GO:0016477 | cell migration | 2.45% (5/204) | 2.12 | 0.006243 | 0.034093 |
GO:0035150 | regulation of tube size | 0.98% (2/204) | 4.06 | 0.00638 | 0.03423 |
GO:0001764 | neuron migration | 0.98% (2/204) | 4.06 | 0.00638 | 0.03423 |
GO:0035265 | organ growth | 0.98% (2/204) | 4.06 | 0.00638 | 0.03423 |
GO:0040025 | vulval development | 0.98% (2/204) | 4.06 | 0.00638 | 0.03423 |
GO:0002082 | regulation of oxidative phosphorylation | 0.98% (2/204) | 4.06 | 0.00638 | 0.03423 |
GO:1990381 | ubiquitin-specific protease binding | 0.98% (2/204) | 4.06 | 0.00638 | 0.03423 |
GO:0031114 | regulation of microtubule depolymerization | 0.98% (2/204) | 4.06 | 0.00638 | 0.03423 |
GO:0006882 | cellular zinc ion homeostasis | 0.98% (2/204) | 4.06 | 0.00638 | 0.03423 |
GO:0045610 | regulation of hemocyte differentiation | 0.98% (2/204) | 4.06 | 0.00638 | 0.03423 |
GO:0035970 | peptidyl-threonine dephosphorylation | 0.98% (2/204) | 4.06 | 0.00638 | 0.03423 |
GO:0080135 | regulation of cellular response to stress | 4.9% (10/204) | 1.35 | 0.006339 | 0.03457 |
GO:0009166 | nucleotide catabolic process | 1.96% (4/204) | 2.45 | 0.006359 | 0.034625 |
GO:0019003 | GDP binding | 1.47% (3/204) | 2.98 | 0.006663 | 0.035694 |
GO:0006473 | protein acetylation | 2.45% (5/204) | 2.09 | 0.006722 | 0.035957 |
GO:0033239 | negative regulation of cellular amine metabolic process | 0.98% (2/204) | 4.0 | 0.006936 | 0.036465 |
GO:0007416 | synapse assembly | 0.98% (2/204) | 4.0 | 0.006936 | 0.036465 |
GO:0031113 | regulation of microtubule polymerization | 0.98% (2/204) | 4.0 | 0.006936 | 0.036465 |
GO:0110156 | methylguanosine-cap decapping | 0.98% (2/204) | 4.0 | 0.006936 | 0.036465 |
GO:0030118 | clathrin coat | 0.98% (2/204) | 4.0 | 0.006936 | 0.036465 |
GO:0000178 | exosome (RNase complex) | 0.98% (2/204) | 4.0 | 0.006936 | 0.036465 |
GO:1905354 | exoribonuclease complex | 0.98% (2/204) | 4.0 | 0.006936 | 0.036465 |
GO:0000049 | tRNA binding | 1.47% (3/204) | 2.96 | 0.006918 | 0.036738 |
GO:0010952 | positive regulation of peptidase activity | 1.47% (3/204) | 2.96 | 0.006918 | 0.036738 |
GO:0071326 | cellular response to monosaccharide stimulus | 1.47% (3/204) | 2.96 | 0.006918 | 0.036738 |
GO:0071331 | cellular response to hexose stimulus | 1.47% (3/204) | 2.96 | 0.006918 | 0.036738 |
GO:0071333 | cellular response to glucose stimulus | 1.47% (3/204) | 2.96 | 0.006918 | 0.036738 |
GO:0060828 | regulation of canonical Wnt signaling pathway | 1.96% (4/204) | 2.41 | 0.007013 | 0.036814 |
GO:0052547 | regulation of peptidase activity | 2.45% (5/204) | 2.07 | 0.007097 | 0.037205 |
GO:0001933 | negative regulation of protein phosphorylation | 1.96% (4/204) | 2.4 | 0.007183 | 0.037385 |
GO:1901984 | negative regulation of protein acetylation | 1.47% (3/204) | 2.94 | 0.007179 | 0.037418 |
GO:0006140 | regulation of nucleotide metabolic process | 1.47% (3/204) | 2.94 | 0.007179 | 0.037418 |
GO:0001678 | cellular glucose homeostasis | 1.47% (3/204) | 2.94 | 0.007179 | 0.037418 |
GO:0009116 | nucleoside metabolic process | 1.47% (3/204) | 2.94 | 0.007179 | 0.037418 |
GO:0060548 | negative regulation of cell death | 4.41% (9/204) | 1.41 | 0.007318 | 0.038036 |
GO:0009749 | response to glucose | 2.45% (5/204) | 2.06 | 0.007356 | 0.038177 |
GO:0005677 | chromatin silencing complex | 0.98% (2/204) | 3.94 | 0.007514 | 0.038505 |
GO:0071243 | cellular response to arsenic-containing substance | 0.98% (2/204) | 3.94 | 0.007514 | 0.038505 |
GO:0031420 | alkali metal ion binding | 0.98% (2/204) | 3.94 | 0.007514 | 0.038505 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 0.98% (2/204) | 3.94 | 0.007514 | 0.038505 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 0.98% (2/204) | 3.94 | 0.007514 | 0.038505 |
GO:0046040 | IMP metabolic process | 0.98% (2/204) | 3.94 | 0.007514 | 0.038505 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 0.98% (2/204) | 3.94 | 0.007514 | 0.038505 |
GO:0043021 | ribonucleoprotein complex binding | 2.45% (5/204) | 2.05 | 0.007487 | 0.03875 |
GO:0051090 | regulation of DNA-binding transcription factor activity | 2.45% (5/204) | 2.05 | 0.007487 | 0.03875 |
GO:2000059 | negative regulation of ubiquitin-dependent protein catabolic process | 1.47% (3/204) | 2.9 | 0.007718 | 0.039332 |
GO:0140318 | protein transporter activity | 1.47% (3/204) | 2.9 | 0.007718 | 0.039332 |
GO:0048534 | hematopoietic or lymphoid organ development | 1.96% (4/204) | 2.37 | 0.007709 | 0.039398 |
GO:0140110 | transcription regulator activity | 9.8% (20/204) | 0.86 | 0.007703 | 0.039418 |
GO:0032990 | cell part morphogenesis | 1.96% (4/204) | 2.36 | 0.00789 | 0.040098 |
GO:1901292 | nucleoside phosphate catabolic process | 1.96% (4/204) | 2.36 | 0.00789 | 0.040098 |
GO:0051640 | organelle localization | 3.92% (8/204) | 1.5 | 0.007944 | 0.040316 |
GO:0090734 | site of DNA damage | 1.47% (3/204) | 2.88 | 0.007996 | 0.040525 |
GO:0010019 | chloroplast-nucleus signaling pathway | 0.98% (2/204) | 3.88 | 0.008112 | 0.04066 |
GO:0030970 | retrograde protein transport, ER to cytosol | 0.98% (2/204) | 3.88 | 0.008112 | 0.04066 |
GO:1903513 | endoplasmic reticulum to cytosol transport | 0.98% (2/204) | 3.88 | 0.008112 | 0.04066 |
GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 0.98% (2/204) | 3.88 | 0.008112 | 0.04066 |
GO:0110154 | RNA decapping | 0.98% (2/204) | 3.88 | 0.008112 | 0.04066 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 0.98% (2/204) | 3.88 | 0.008112 | 0.04066 |
GO:0035066 | positive regulation of histone acetylation | 0.98% (2/204) | 3.88 | 0.008112 | 0.04066 |
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 0.98% (2/204) | 3.88 | 0.008112 | 0.04066 |
GO:0031648 | protein destabilization | 1.47% (3/204) | 2.86 | 0.008281 | 0.041448 |
GO:0010506 | regulation of autophagy | 2.45% (5/204) | 2.02 | 0.008312 | 0.041548 |
GO:0022618 | ribonucleoprotein complex assembly | 2.94% (6/204) | 1.78 | 0.008571 | 0.042784 |
GO:0006479 | protein methylation | 2.45% (5/204) | 2.0 | 0.008747 | 0.043075 |
GO:0008213 | protein alkylation | 2.45% (5/204) | 2.0 | 0.008747 | 0.043075 |
GO:0043025 | neuronal cell body | 2.45% (5/204) | 2.0 | 0.008747 | 0.043075 |
GO:2000082 | regulation of L-ascorbic acid biosynthetic process | 0.98% (2/204) | 3.83 | 0.008731 | 0.043172 |
GO:0032648 | regulation of interferon-beta production | 0.98% (2/204) | 3.83 | 0.008731 | 0.043172 |
GO:0019985 | translesion synthesis | 0.98% (2/204) | 3.83 | 0.008731 | 0.043172 |
GO:0071712 | ER-associated misfolded protein catabolic process | 0.98% (2/204) | 3.83 | 0.008731 | 0.043172 |
GO:0046827 | positive regulation of protein export from nucleus | 0.98% (2/204) | 3.83 | 0.008731 | 0.043172 |
GO:0008409 | 5'-3' exonuclease activity | 0.98% (2/204) | 3.83 | 0.008731 | 0.043172 |
GO:0014015 | positive regulation of gliogenesis | 0.98% (2/204) | 3.83 | 0.008731 | 0.043172 |
GO:0045995 | regulation of embryonic development | 1.96% (4/204) | 2.32 | 0.008837 | 0.043462 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.47% (3/204) | 2.83 | 0.008867 | 0.043547 |
GO:0046983 | protein dimerization activity | 7.84% (16/204) | 0.96 | 0.009044 | 0.044357 |
GO:1903828 | negative regulation of protein localization | 1.96% (4/204) | 2.3 | 0.009236 | 0.04524 |
GO:0042726 | flavin-containing compound metabolic process | 0.98% (2/204) | 3.77 | 0.009371 | 0.045535 |
GO:0042439 | ethanolamine-containing compound metabolic process | 0.98% (2/204) | 3.77 | 0.009371 | 0.045535 |
GO:0016514 | SWI/SNF complex | 0.98% (2/204) | 3.77 | 0.009371 | 0.045535 |
GO:0071027 | nuclear RNA surveillance | 0.98% (2/204) | 3.77 | 0.009371 | 0.045535 |
GO:0031468 | nuclear membrane reassembly | 0.98% (2/204) | 3.77 | 0.009371 | 0.045535 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 0.98% (2/204) | 3.77 | 0.009371 | 0.045535 |
GO:0051301 | cell division | 4.41% (9/204) | 1.35 | 0.009406 | 0.045646 |
GO:0000151 | ubiquitin ligase complex | 3.43% (7/204) | 1.56 | 0.010412 | 0.045737 |
GO:1903051 | negative regulation of proteolysis involved in protein catabolic process | 1.47% (3/204) | 2.74 | 0.010436 | 0.045785 |
GO:0019448 | L-cysteine catabolic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0019450 | L-cysteine catabolic process to pyruvate | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0046439 | L-cysteine metabolic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0043220 | Schmidt-Lanterman incisure | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0072044 | collecting duct development | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0039689 | negative stranded viral RNA replication | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0070255 | regulation of mucus secretion | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0070257 | positive regulation of mucus secretion | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:2000619 | negative regulation of histone H4-K16 acetylation | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0031934 | mating-type region heterochromatin | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0046331 | lateral inhibition | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0016031 | tRNA import into mitochondrion | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0035927 | RNA import into mitochondrion | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0000393 | spliceosomal conformational changes to generate catalytic conformation | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0071001 | U4/U6 snRNP | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0045346 | regulation of MHC class II biosynthetic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0003876 | AMP deaminase activity | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0006178 | guanine salvage | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0046032 | ADP catabolic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0046099 | guanine biosynthetic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0047623 | adenosine-phosphate deaminase activity | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0002475 | antigen processing and presentation via MHC class Ib | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0048007 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0051136 | regulation of NK T cell differentiation | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0051138 | positive regulation of NK T cell differentiation | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0060155 | platelet dense granule organization | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0035718 | macrophage migration inhibitory factor binding | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0004660 | protein farnesyltransferase activity | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0005953 | CAAX-protein geranylgeranyltransferase complex | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0005965 | protein farnesyltransferase complex | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0007323 | peptide pheromone maturation | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0018343 | protein farnesylation | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0046537 | 2,3-bisphosphoglycerate-independent phosphoglycerate mutase activity | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0046692 | sperm competition | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0017172 | cysteine dioxygenase activity | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0006249 | dCMP catabolic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0046050 | UMP catabolic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0046063 | dCMP metabolic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0046079 | dUMP catabolic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0004019 | adenylosuccinate synthase activity | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0001164 | RNA polymerase I core promoter sequence-specific DNA binding | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:1900110 | negative regulation of histone H3-K9 dimethylation | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:1901044 | protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0002068 | glandular epithelial cell development | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0003323 | type B pancreatic cell development | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0035596 | methylthiotransferase activity | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0035600 | tRNA methylthiolation | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0050497 | alkylthioltransferase activity | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0008579 | JUN kinase phosphatase activity | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0045906 | negative regulation of vasoconstriction | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0120276 | regulation of cerebral blood circulation | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0120277 | positive regulation of cerebral blood circulation | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0051434 | BH3 domain binding | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0070513 | death domain binding | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:1990630 | IRE1-RACK1-PP2A complex | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0034286 | response to maltose | 0.49% (1/204) | 6.58 | 0.010411 | 0.045785 |
GO:0005929 | cilium | 1.96% (4/204) | 2.24 | 0.010501 | 0.046018 |
GO:1903320 | regulation of protein modification by small protein conjugation or removal | 2.45% (5/204) | 1.97 | 0.009507 | 0.046072 |
GO:0007030 | Golgi organization | 1.96% (4/204) | 2.28 | 0.009646 | 0.046563 |
GO:0072666 | establishment of protein localization to vacuole | 1.96% (4/204) | 2.28 | 0.009646 | 0.046563 |
GO:0008135 | translation factor activity, RNA binding | 1.96% (4/204) | 2.28 | 0.009646 | 0.046563 |
GO:0001669 | acrosomal vesicle | 0.98% (2/204) | 3.68 | 0.01071 | 0.046654 |
GO:0007622 | rhythmic behavior | 0.98% (2/204) | 3.68 | 0.01071 | 0.046654 |
GO:0140747 | regulation of ncRNA transcription | 0.98% (2/204) | 3.68 | 0.01071 | 0.046654 |
GO:0031594 | neuromuscular junction | 0.98% (2/204) | 3.68 | 0.01071 | 0.046654 |
GO:1901985 | positive regulation of protein acetylation | 0.98% (2/204) | 3.68 | 0.01071 | 0.046654 |
GO:0009967 | positive regulation of signal transduction | 5.88% (12/204) | 1.1 | 0.01083 | 0.047006 |
GO:0048609 | multicellular organismal reproductive process | 5.88% (12/204) | 1.1 | 0.01083 | 0.047006 |
GO:0003727 | single-stranded RNA binding | 2.45% (5/204) | 1.92 | 0.010814 | 0.047051 |
GO:0048583 | regulation of response to stimulus | 19.61% (40/204) | 0.53 | 0.009822 | 0.047351 |
GO:0043066 | negative regulation of apoptotic process | 3.43% (7/204) | 1.57 | 0.009843 | 0.04739 |
GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 1.96% (4/204) | 2.22 | 0.010947 | 0.047458 |
GO:0051051 | negative regulation of transport | 2.45% (5/204) | 1.92 | 0.010986 | 0.047572 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 1.47% (3/204) | 2.71 | 0.011106 | 0.047976 |
GO:0016592 | mediator complex | 1.47% (3/204) | 2.71 | 0.011106 | 0.047976 |
GO:0005662 | DNA replication factor A complex | 0.98% (2/204) | 3.72 | 0.010031 | 0.047976 |
GO:0048512 | circadian behavior | 0.98% (2/204) | 3.72 | 0.010031 | 0.047976 |
GO:0048592 | eye morphogenesis | 0.98% (2/204) | 3.72 | 0.010031 | 0.047976 |
GO:0043328 | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 0.98% (2/204) | 3.72 | 0.010031 | 0.047976 |
GO:0051963 | regulation of synapse assembly | 0.98% (2/204) | 3.72 | 0.010031 | 0.047976 |
GO:0048869 | cellular developmental process | 12.25% (25/204) | 0.71 | 0.010063 | 0.04807 |
GO:0031047 | gene silencing by RNA | 2.45% (5/204) | 1.91 | 0.01116 | 0.048095 |
GO:0007005 | mitochondrion organization | 2.45% (5/204) | 1.91 | 0.01116 | 0.048095 |
GO:0032989 | cellular component morphogenesis | 1.96% (4/204) | 2.22 | 0.011174 | 0.048102 |
GO:0033120 | positive regulation of RNA splicing | 1.47% (3/204) | 2.76 | 0.01011 | 0.048167 |
GO:1905897 | regulation of response to endoplasmic reticulum stress | 1.47% (3/204) | 2.76 | 0.01011 | 0.048167 |
GO:0015631 | tubulin binding | 2.94% (6/204) | 1.69 | 0.011325 | 0.048695 |
GO:0060236 | regulation of mitotic spindle organization | 0.98% (2/204) | 3.63 | 0.01141 | 0.048887 |
GO:0071025 | RNA surveillance | 0.98% (2/204) | 3.63 | 0.01141 | 0.048887 |
GO:0004860 | protein kinase inhibitor activity | 0.98% (2/204) | 3.63 | 0.01141 | 0.048887 |
GO:0030422 | siRNA processing | 1.47% (3/204) | 2.69 | 0.01145 | 0.048999 |
GO:0006412 | translation | 3.43% (7/204) | 1.53 | 0.011497 | 0.049144 |
GO:0006810 | transport | 16.67% (34/204) | 0.59 | 0.010342 | 0.049207 |
GO:0051234 | establishment of localization | 17.16% (35/204) | 0.57 | 0.011577 | 0.049429 |